Venture Capital

Venture Firm Can’t Escape OvaScience IVF Suit, Judge Says

Read more at www.law360.com

Law360 (May 28, 2021, 5:31 PM EDT) — A Massachusetts federal judge said Friday securities fraud claims against a venture capital firm that was “running the show” at a fertility treatment company could go forward, rejecting arguments that the claims were late-raised by lead plaintiffs in the investor class action.

In her order denying efforts from OvaScience and the new defendants — Longwood Fund, and its founding member, Richard Aldrich — to strike and dismiss the claims, U.S. District Judge Indira Talwani rejected arguments that the two-year statute of limitations for the claims started running in 2015 when the company admitted the sales of its in vitro fertilization treatment were far…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Read more at www.law360.com

Show More

Related Articles

Back to top button